Description
An endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA; acts on CB1 receptors with a potency and efficacy similar to that of AEA but its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated
Formal name: N-(2-hydroxyethyl)-7Z,10Z,13Z,16Z-docosatetraenamide
Synonyms: DEA
Molecular weight: 375.6
CAS: 150314-35-5
Purity: ≥98%
Formulation: A solution in ethanol